Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC-Norfolk prospective population-based cohort study. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15261
PubMed Identifier: 35118716
Publication URI: http://europepmc.org/abstract/MED/35118716
Type: Journal Article/Review
Volume: 88
Parent Publication: British journal of clinical pharmacology
Issue: 7
ISSN: 0306-5251